Novo Nordisk stock pre-market at EUR 33.91
Published on 10/14/2026 at 08:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTrading day reference points
- The Xetra session is scheduled to begin at 9:00 a.m. CEST on October 14, 2026.
- A EUR 34.00 round-number level is 0.27 percent above the pre-market price.
- The NVO finance quote showed a price-earnings ratio of 9.80 as of October 13, 2026.
Novo Nordisk stock is at EUR 33.91 in pre-market trading at Lang & Schwarz on October 14, 2026, at 8:01 a.m. CEST. The displayed bid is EUR 33.85 and the ask is EUR 33.96.
Price before the Xetra open
The quote places the stock below the EUR 34.00 round-number level by 0.27 percent. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Novo Nordisk stock.
What matters today
The Xetra session is scheduled to begin at 9:00 a.m. CEST on October 14, 2026. The next round-number price level is EUR 34.00, which is 0.27 percent above the Lang & Schwarz price. A finance quote for NVO showed a price-earnings ratio of 9.80 as of October 13, 2026.
Issuer reference
Novo Nordisk’s investor-relations page identifies the issuer as Novo Nordisk A/S and lists its headquarters in Bagsværd, Denmark.
Market context: Latest market reports.
